Funding for this research was provided by:
National Natural Science Foundation of China (81760542)
Scientific Research and Technology Development Program of Guangxi (2016GXNSFAA380252)
U.S. Department of Defense (W81XWH-15-1-0221)
Discovery To Cure
Guangxi Medical University Training Program For Distinguished Young Scholars
The First Affiliated Hospital of Guangxi Medical University
Colleen's Dream Foundation
Received: 30 June 2020
Accepted: 12 August 2020
First Online: 14 September 2020
Ethics approval and consent to participate
: The clinical study protocol was approved by the Human Research Ethics Committee of the First Affiliated Hospital of Guangxi Medical University. The procedures are in accordance with the Helsinki Declaration of 1975. Written informed consent was obtained from all participants. Animal experiments were approved by the institutional committee at The First Affiliated Hospital of Guangxi Medical University.
: Not applicable.
: The authors declare that they have no competing interests.